DADUN
Therapeutic vaccines against hepatocellular carcinoma in the immune checkpoint inhibitor era: time for neoantigens?
Interleukin-12 message in a bottle
Advances in mRNA-based drug discovery in cancer immunotherapy
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
Searching for peptide inhibitors of T regulatory cell activity by targeting specific domains of FOXP3 transcription factor
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
